Atlas Trials

Efficacy and Safety Study of MC-1101 1% TID in the Treatment of Nonexudative Age-Related Macular Degeneration

Clinical trial NCT01601483 · TERMINATED

Trial details

NCT number
NCT01601483
Sponsor
MacuCLEAR, Inc.
Status
TERMINATED
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
Nonexudative Age Related Macular Degeneration
Start date
2012-10-01
Primary completion
2013-03-01
Enrollment
22

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.